Retinal Pharmaceuticals Market - Global Outlook and Forecast 2022-2028

March 2022 | 73 pages | ID: R0C859D8AC19EN
Market Monitor Global

Abstracts

Retinal Pharmaceuticals is primarily used to treat retinal-related diseases.

Retina is a layer of nerve tissue lining the back of the eye. Retina receives light and convert it into neural signals, and send these signals to the brain for visual recognition. The central part of the retina is known as macula, which is responsible for central vision. The remaining tissue outside the macula is responsible for peripheral vision. There are many types of retinal diseases.

This report contains market size and forecasts of Retinal Pharmaceuticals in global, including the following market information:

Global Retinal Pharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Retinal Pharmaceuticals Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Retinal Pharmaceuticals companies in 2021 (%)

The global Retinal Pharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Macular Degeneration Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Retinal Pharmaceuticals include Santen Pharmaceutical Co.?Ltd., Regeneron Pharmaceuticals?Inc., Takeda, Bayer AG, Novartis International AG, Valeant Pharmaceuticals International?Inc and Merck?Co., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Retinal Pharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Retinal Pharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Retinal Pharmaceuticals Market Segment Percentages, by Type, 2021 (%)

• Macular Degeneration
• Diabetic Eye Disease
• Retinal Detachment
• Retinoblastoma
• Macular Pucker
• Macular Hole
• Others

Global Retinal Pharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Retinal Pharmaceuticals Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Online Pharmacies
• Independent Pharmacies

Global Retinal Pharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Retinal Pharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Retinal Pharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Retinal Pharmaceuticals revenues share in global market, 2021 (%)

Key companies Retinal Pharmaceuticals sales in global market, 2017-2022 (Estimated), (MT)

Key companies Retinal Pharmaceuticals sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Santen Pharmaceutical Co.?Ltd.
• Regeneron Pharmaceuticals?Inc.
• Takeda
• Bayer AG
• Novartis International AG
• Valeant Pharmaceuticals International?Inc
• Merck?Co.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Retinal Pharmaceuticals Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Retinal Pharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RETINAL PHARMACEUTICALS OVERALL MARKET SIZE

2.1 Global Retinal Pharmaceuticals Market Size: 2021 VS 2028
2.2 Global Retinal Pharmaceuticals Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Retinal Pharmaceuticals Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Retinal Pharmaceuticals Players in Global Market
3.2 Top Global Retinal Pharmaceuticals Companies Ranked by Revenue
3.3 Global Retinal Pharmaceuticals Revenue by Companies
3.4 Global Retinal Pharmaceuticals Sales by Companies
3.5 Global Retinal Pharmaceuticals Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Retinal Pharmaceuticals Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Retinal Pharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Retinal Pharmaceuticals Players in Global Market
  3.8.1 List of Global Tier 1 Retinal Pharmaceuticals Companies
  3.8.2 List of Global Tier 2 and Tier 3 Retinal Pharmaceuticals Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Retinal Pharmaceuticals Market Size Markets, 2021 & 2028
  4.1.2 Macular Degeneration
  4.1.3 Diabetic Eye Disease
  4.1.4 Retinal Detachment
  4.1.5 Retinoblastoma
  4.1.6 Macular Pucker
  4.1.7 Macular Hole
  4.1.8 Others
4.2 By Type - Global Retinal Pharmaceuticals Revenue & Forecasts
  4.2.1 By Type - Global Retinal Pharmaceuticals Revenue, 2017-2022
  4.2.2 By Type - Global Retinal Pharmaceuticals Revenue, 2023-2028
  4.2.3 By Type - Global Retinal Pharmaceuticals Revenue Market Share, 2017-2028
4.3 By Type - Global Retinal Pharmaceuticals Sales & Forecasts
  4.3.1 By Type - Global Retinal Pharmaceuticals Sales, 2017-2022
  4.3.2 By Type - Global Retinal Pharmaceuticals Sales, 2023-2028
  4.3.3 By Type - Global Retinal Pharmaceuticals Sales Market Share, 2017-2028
4.4 By Type - Global Retinal Pharmaceuticals Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Retinal Pharmaceuticals Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Online Pharmacies
  5.1.4 Independent Pharmacies
5.2 By Application - Global Retinal Pharmaceuticals Revenue & Forecasts
  5.2.1 By Application - Global Retinal Pharmaceuticals Revenue, 2017-2022
  5.2.2 By Application - Global Retinal Pharmaceuticals Revenue, 2023-2028
  5.2.3 By Application - Global Retinal Pharmaceuticals Revenue Market Share, 2017-2028
5.3 By Application - Global Retinal Pharmaceuticals Sales & Forecasts
  5.3.1 By Application - Global Retinal Pharmaceuticals Sales, 2017-2022
  5.3.2 By Application - Global Retinal Pharmaceuticals Sales, 2023-2028
  5.3.3 By Application - Global Retinal Pharmaceuticals Sales Market Share, 2017-2028
5.4 By Application - Global Retinal Pharmaceuticals Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Retinal Pharmaceuticals Market Size, 2021 & 2028
6.2 By Region - Global Retinal Pharmaceuticals Revenue & Forecasts
  6.2.1 By Region - Global Retinal Pharmaceuticals Revenue, 2017-2022
  6.2.2 By Region - Global Retinal Pharmaceuticals Revenue, 2023-2028
  6.2.3 By Region - Global Retinal Pharmaceuticals Revenue Market Share, 2017-2028
6.3 By Region - Global Retinal Pharmaceuticals Sales & Forecasts
  6.3.1 By Region - Global Retinal Pharmaceuticals Sales, 2017-2022
  6.3.2 By Region - Global Retinal Pharmaceuticals Sales, 2023-2028
  6.3.3 By Region - Global Retinal Pharmaceuticals Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Retinal Pharmaceuticals Revenue, 2017-2028
  6.4.2 By Country - North America Retinal Pharmaceuticals Sales, 2017-2028
  6.4.3 US Retinal Pharmaceuticals Market Size, 2017-2028
  6.4.4 Canada Retinal Pharmaceuticals Market Size, 2017-2028
  6.4.5 Mexico Retinal Pharmaceuticals Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Retinal Pharmaceuticals Revenue, 2017-2028
  6.5.2 By Country - Europe Retinal Pharmaceuticals Sales, 2017-2028
  6.5.3 Germany Retinal Pharmaceuticals Market Size, 2017-2028
  6.5.4 France Retinal Pharmaceuticals Market Size, 2017-2028
  6.5.5 U.K. Retinal Pharmaceuticals Market Size, 2017-2028
  6.5.6 Italy Retinal Pharmaceuticals Market Size, 2017-2028
  6.5.7 Russia Retinal Pharmaceuticals Market Size, 2017-2028
  6.5.8 Nordic Countries Retinal Pharmaceuticals Market Size, 2017-2028
  6.5.9 Benelux Retinal Pharmaceuticals Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Retinal Pharmaceuticals Revenue, 2017-2028
  6.6.2 By Region - Asia Retinal Pharmaceuticals Sales, 2017-2028
  6.6.3 China Retinal Pharmaceuticals Market Size, 2017-2028
  6.6.4 Japan Retinal Pharmaceuticals Market Size, 2017-2028
  6.6.5 South Korea Retinal Pharmaceuticals Market Size, 2017-2028
  6.6.6 Southeast Asia Retinal Pharmaceuticals Market Size, 2017-2028
  6.6.7 India Retinal Pharmaceuticals Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Retinal Pharmaceuticals Revenue, 2017-2028
  6.7.2 By Country - South America Retinal Pharmaceuticals Sales, 2017-2028
  6.7.3 Brazil Retinal Pharmaceuticals Market Size, 2017-2028
  6.7.4 Argentina Retinal Pharmaceuticals Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Retinal Pharmaceuticals Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Retinal Pharmaceuticals Sales, 2017-2028
  6.8.3 Turkey Retinal Pharmaceuticals Market Size, 2017-2028
  6.8.4 Israel Retinal Pharmaceuticals Market Size, 2017-2028
  6.8.5 Saudi Arabia Retinal Pharmaceuticals Market Size, 2017-2028
  6.8.6 UAE Retinal Pharmaceuticals Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Santen Pharmaceutical Co.,Ltd.
  7.1.1 Santen Pharmaceutical Co.,Ltd. Corporate Summary
  7.1.2 Santen Pharmaceutical Co.,Ltd. Business Overview
  7.1.3 Santen Pharmaceutical Co.,Ltd. Retinal Pharmaceuticals Major Product Offerings
  7.1.4 Santen Pharmaceutical Co.,Ltd. Retinal Pharmaceuticals Sales and Revenue in Global (2017-2022)
  7.1.5 Santen Pharmaceutical Co.,Ltd. Key News
7.2 Regeneron Pharmaceuticals,Inc.
  7.2.1 Regeneron Pharmaceuticals,Inc. Corporate Summary
  7.2.2 Regeneron Pharmaceuticals,Inc. Business Overview
  7.2.3 Regeneron Pharmaceuticals,Inc. Retinal Pharmaceuticals Major Product Offerings
  7.2.4 Regeneron Pharmaceuticals,Inc. Retinal Pharmaceuticals Sales and Revenue in Global (2017-2022)
  7.2.5 Regeneron Pharmaceuticals,Inc. Key News
7.3 Takeda
  7.3.1 Takeda Corporate Summary
  7.3.2 Takeda Business Overview
  7.3.3 Takeda Retinal Pharmaceuticals Major Product Offerings
  7.3.4 Takeda Retinal Pharmaceuticals Sales and Revenue in Global (2017-2022)
  7.3.5 Takeda Key News
7.4 Bayer AG
  7.4.1 Bayer AG Corporate Summary
  7.4.2 Bayer AG Business Overview
  7.4.3 Bayer AG Retinal Pharmaceuticals Major Product Offerings
  7.4.4 Bayer AG Retinal Pharmaceuticals Sales and Revenue in Global (2017-2022)
  7.4.5 Bayer AG Key News
7.5 Novartis International AG
  7.5.1 Novartis International AG Corporate Summary
  7.5.2 Novartis International AG Business Overview
  7.5.3 Novartis International AG Retinal Pharmaceuticals Major Product Offerings
  7.5.4 Novartis International AG Retinal Pharmaceuticals Sales and Revenue in Global (2017-2022)
  7.5.5 Novartis International AG Key News
7.6 Valeant Pharmaceuticals International,Inc
  7.6.1 Valeant Pharmaceuticals International,Inc Corporate Summary
  7.6.2 Valeant Pharmaceuticals International,Inc Business Overview
  7.6.3 Valeant Pharmaceuticals International,Inc Retinal Pharmaceuticals Major Product Offerings
  7.6.4 Valeant Pharmaceuticals International,Inc Retinal Pharmaceuticals Sales and Revenue in Global (2017-2022)
  7.6.5 Valeant Pharmaceuticals International,Inc Key News
7.7 Merck&Co.
  7.7.1 Merck&Co. Corporate Summary
  7.7.2 Merck&Co. Business Overview
  7.7.3 Merck&Co. Retinal Pharmaceuticals Major Product Offerings
  7.7.4 Merck&Co. Retinal Pharmaceuticals Sales and Revenue in Global (2017-2022)
  7.7.5 Merck&Co. Key News

8 GLOBAL RETINAL PHARMACEUTICALS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Retinal Pharmaceuticals Production Capacity, 2017-2028
8.2 Retinal Pharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global Retinal Pharmaceuticals Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 RETINAL PHARMACEUTICALS SUPPLY CHAIN ANALYSIS

10.1 Retinal Pharmaceuticals Industry Value Chain
10.2 Retinal Pharmaceuticals Upstream Market
10.3 Retinal Pharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Retinal Pharmaceuticals Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Retinal Pharmaceuticals in Global Market
Table 2. Top Retinal Pharmaceuticals Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Retinal Pharmaceuticals Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Retinal Pharmaceuticals Revenue Share by Companies, 2017-2022
Table 5. Global Retinal Pharmaceuticals Sales by Companies, (MT), 2017-2022
Table 6. Global Retinal Pharmaceuticals Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Retinal Pharmaceuticals Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Retinal Pharmaceuticals Product Type
Table 9. List of Global Tier 1 Retinal Pharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retinal Pharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Retinal Pharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Retinal Pharmaceuticals Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Retinal Pharmaceuticals Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Retinal Pharmaceuticals Sales (MT), 2017-2022
Table 15. By Type - Global Retinal Pharmaceuticals Sales (MT), 2023-2028
Table 16. By Application – Global Retinal Pharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Retinal Pharmaceuticals Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Retinal Pharmaceuticals Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Retinal Pharmaceuticals Sales (MT), 2017-2022
Table 20. By Application - Global Retinal Pharmaceuticals Sales (MT), 2023-2028
Table 21. By Region – Global Retinal Pharmaceuticals Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Retinal Pharmaceuticals Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Retinal Pharmaceuticals Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Retinal Pharmaceuticals Sales (MT), 2017-2022
Table 25. By Region - Global Retinal Pharmaceuticals Sales (MT), 2023-2028
Table 26. By Country - North America Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Retinal Pharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Retinal Pharmaceuticals Sales, (MT), 2017-2022
Table 29. By Country - North America Retinal Pharmaceuticals Sales, (MT), 2023-2028
Table 30. By Country - Europe Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Retinal Pharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Retinal Pharmaceuticals Sales, (MT), 2017-2022
Table 33. By Country - Europe Retinal Pharmaceuticals Sales, (MT), 2023-2028
Table 34. By Region - Asia Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Retinal Pharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Retinal Pharmaceuticals Sales, (MT), 2017-2022
Table 37. By Region - Asia Retinal Pharmaceuticals Sales, (MT), 2023-2028
Table 38. By Country - South America Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Retinal Pharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Retinal Pharmaceuticals Sales, (MT), 2017-2022
Table 41. By Country - South America Retinal Pharmaceuticals Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Retinal Pharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Retinal Pharmaceuticals Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Retinal Pharmaceuticals Sales, (MT), 2023-2028
Table 46. Santen Pharmaceutical Co.,Ltd. Corporate Summary
Table 47. Santen Pharmaceutical Co.,Ltd. Retinal Pharmaceuticals Product Offerings
Table 48. Santen Pharmaceutical Co.,Ltd. Retinal Pharmaceuticals Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Regeneron Pharmaceuticals,Inc. Corporate Summary
Table 50. Regeneron Pharmaceuticals,Inc. Retinal Pharmaceuticals Product Offerings
Table 51. Regeneron Pharmaceuticals,Inc. Retinal Pharmaceuticals Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Takeda Corporate Summary
Table 53. Takeda Retinal Pharmaceuticals Product Offerings
Table 54. Takeda Retinal Pharmaceuticals Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Bayer AG Corporate Summary
Table 56. Bayer AG Retinal Pharmaceuticals Product Offerings
Table 57. Bayer AG Retinal Pharmaceuticals Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Novartis International AG Corporate Summary
Table 59. Novartis International AG Retinal Pharmaceuticals Product Offerings
Table 60. Novartis International AG Retinal Pharmaceuticals Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Valeant Pharmaceuticals International,Inc Corporate Summary
Table 62. Valeant Pharmaceuticals International,Inc Retinal Pharmaceuticals Product Offerings
Table 63. Valeant Pharmaceuticals International,Inc Retinal Pharmaceuticals Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Merck&Co. Corporate Summary
Table 65. Merck&Co. Retinal Pharmaceuticals Product Offerings
Table 66. Merck&Co. Retinal Pharmaceuticals Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Retinal Pharmaceuticals Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 68. Global Retinal Pharmaceuticals Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Retinal Pharmaceuticals Production by Region, 2017-2022 (MT)
Table 70. Global Retinal Pharmaceuticals Production by Region, 2023-2028 (MT)
Table 71. Retinal Pharmaceuticals Market Opportunities & Trends in Global Market
Table 72. Retinal Pharmaceuticals Market Drivers in Global Market
Table 73. Retinal Pharmaceuticals Market Restraints in Global Market
Table 74. Retinal Pharmaceuticals Raw Materials
Table 75. Retinal Pharmaceuticals Raw Materials Suppliers in Global Market
Table 76. Typical Retinal Pharmaceuticals Downstream
Table 77. Retinal Pharmaceuticals Downstream Clients in Global Market
Table 78. Retinal Pharmaceuticals Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Retinal Pharmaceuticals Segment by Type
Figure 2. Retinal Pharmaceuticals Segment by Application
Figure 3. Global Retinal Pharmaceuticals Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Retinal Pharmaceuticals Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Retinal Pharmaceuticals Revenue, 2017-2028 (US$, Mn)
Figure 7. Retinal Pharmaceuticals Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Retinal Pharmaceuticals Revenue in 2021
Figure 9. By Type - Global Retinal Pharmaceuticals Sales Market Share, 2017-2028
Figure 10. By Type - Global Retinal Pharmaceuticals Revenue Market Share, 2017-2028
Figure 11. By Type - Global Retinal Pharmaceuticals Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Retinal Pharmaceuticals Sales Market Share, 2017-2028
Figure 13. By Application - Global Retinal Pharmaceuticals Revenue Market Share, 2017-2028
Figure 14. By Application - Global Retinal Pharmaceuticals Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Retinal Pharmaceuticals Sales Market Share, 2017-2028
Figure 16. By Region - Global Retinal Pharmaceuticals Revenue Market Share, 2017-2028
Figure 17. By Country - North America Retinal Pharmaceuticals Revenue Market Share, 2017-2028
Figure 18. By Country - North America Retinal Pharmaceuticals Sales Market Share, 2017-2028
Figure 19. US Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Retinal Pharmaceuticals Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Retinal Pharmaceuticals Sales Market Share, 2017-2028
Figure 24. Germany Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 25. France Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Retinal Pharmaceuticals Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Retinal Pharmaceuticals Sales Market Share, 2017-2028
Figure 33. China Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 37. India Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Retinal Pharmaceuticals Revenue Market Share, 2017-2028
Figure 39. By Country - South America Retinal Pharmaceuticals Sales Market Share, 2017-2028
Figure 40. Brazil Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Retinal Pharmaceuticals Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Retinal Pharmaceuticals Sales Market Share, 2017-2028
Figure 44. Turkey Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Retinal Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 48. Global Retinal Pharmaceuticals Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Retinal Pharmaceuticals by Region, 2021 VS 2028
Figure 50. Retinal Pharmaceuticals Industry Value Chain
Figure 51. Marketing Channels